"Recording - Lowering Overhead Burden and Increasing Productivity of Medical Affairs Directors/Medical Science Liaisons - Starter Series Round 2 Pharma Focus"
Copilot for Microsoft 365 is a digital assistant that can help Medical Affairs Directors and Medical Science Liaisons manage their work such as:
- Streamline Presentations
- Better prepare for KOL Engagements
- Easily stay current with the latest publications and clinical trial data related to the disease area you support
- Staying on top of team meetings
- ISS Assessments
- Clinical Trial Calls
In this webinar recording Microsoft’s Helen Guan and Michael Gannotti present how Copilot for Microsoft 365 can benefit medical affairs directors and medical science liaisons. Additionally, Helen takes viewers through two separate use cases with demos of addressing these professional needs.
To See the Entire Webinar Series click here.
Resources:
- Presentation slide deck in PDF format
- HLS Copilot Snacks (microsoft.com)
- Copilot for Microsoft 365 – Microsoft Adoption
- Copilot Success Kit – Microsoft Adoption
- Copilot in Word help & learning (microsoft.com)
- Copilot in PowerPoint help & learning (microsoft.com)
- Copilot in OneNote help & learning (microsoft.com)
- Copilot in Outlook help & learning (microsoft.com)
- Copilot in Excel help & learning (microsoft.com)
- Copilot in Microsoft Teams help & learning
- Microsoft Copilot grounded in your work data
- Copilot in Microsoft Loop help & learning
- Welcome to Copilot in Windows - Microsoft Support
- Copilot in Whiteboard help & learning (microsoft.com)
- Welcome to Copilot in Forms - Microsoft Support
- Learn about Copilot prompts - Microsoft Support
- Copilot prompts Toolkit
- Data, Privacy, and Security for Microsoft Copilot for Microsoft 365 | Microsoft Learn
To See the Entire Webinar Series click here.
Thanks for visiting – Michael Gannotti LinkedIn
Updated Jul 02, 2024
Version 2.0MichaelGannotti
Microsoft
Joined July 15, 2016
Healthcare and Life Sciences Blog
Follow this blog board to get notified when there's new activity